Nippon Life Global Investors Americas’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Nippon Life Global Investors Americas's PFE Position: Q1 2023 in Review
Nippon Life Global Investors Americas sold out of Pfizer (PFE) in Q1 2023, closing a stake of 479,080 shares — an estimated $24.5M sold.
Nippon Life Global Investors Americas first reported a position in PFE in Q2 2013 and held it in 21 quarters. The position peaked at $30.8M in Q4 2021. 3,104 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Nippon Life Global Investors Americas reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
- Nippon Life Global Investors Americas sold 479,080 Pfizer shares in Q1 2023, an estimated $24.5M.
- Nippon Life Global Investors Americas first reported a position in Pfizer in Q2 2013 and held it in 21 quarters.
- Nippon Life Global Investors Americas's Pfizer position peaked at $30.8M in Q4 2021.
- 3,104 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Nippon Life Global Investors Americas's 13F filing for Q1 2023, filed 15 May 2023.